EXTENSION TO THE PAS LACROSSE PTCA CATHETER PRODUCT LINE

FDA Premarket Approval P930012 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Addition of 1. 5mm diameter, 20 mm length balloon; addition of 2. 5mm, 3. 0mm, and 4. 0mm balloons, all with 30mm length; change in rated burst of the 2. 0mm and 2. 5mm balloons with 20mm length

DeviceEXTENSION TO THE PAS LACROSSE PTCA CATHETER PRODUCT LINE
Generic NameCatheters, Transluminal Coronary Angioplasty, Percutaneous
ApplicantPROGRESSIVE ANGIOPLASTY SYSTEMS, INC.
Date Received1995-10-04
Decision Date1996-04-16
PMAP930012
SupplementS002
Product CodeLOX 
Advisory CommitteeCardiovascular
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address PROGRESSIVE ANGIOPLASTY SYSTEMS, INC. 1350 Willow Rd. Suite 201 menlo Park, CA 94025

Supplemental Filings

Supplement NumberDateSupplement Type
P930012Original Filing
S012 1998-07-24 Normal 180 Day Track
S011 1998-08-03 Real-time Process
S010 1998-05-08 Real-time Process
S009 1998-01-08 Real-time Process
S008 1997-08-19 Normal 180 Day Track
S007
S006 1997-03-06 Normal 180 Day Track
S005 1996-08-01 Normal 180 Day Track
S004 1996-06-27 Normal 180 Day Track
S003 1995-11-13 Normal 180 Day Track
S002 1995-10-04 Normal 180 Day Track
S001 1995-10-04 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.